Pfizer to begin Covid vaccine clinical trial in pregnant women
Pfizer-BioNTech said Thursday that it is beginning clinical trials of its Covid-19 vaccine in pregnant women, the first such trials […]
Pfizer-BioNTech said Thursday that it is beginning clinical trials of its Covid-19 vaccine in pregnant women, the first such trials […] Pfizer, the first company to get U.S. emergency use authorization for a COVID-19 vaccine, swung to a small profit in […] Pharma giant Pfizer tried to ease concerns in Europe about deliveries of its coronavirus vaccine as nations across the world […] Britain and Canada have already approved the Pfizer-BioNTech COVID-19 vaccine—will the United States be next? Two dozen independent experts convened […] NEW YORK and MAINZ, GERMANY, October 6, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation […] September 5, 2018 – Pfizer Inc. (NYSE:PFE) today announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough […] July 16, 2018 — Pfizer Inc. (NYSE:PFE) and Spark Therapeutics (NASDAQ:ONCE) announced today that Pfizer initiated a Phase 3 open-label, […]Pfizer
Pfizer to begin Covid vaccine clinical trial in pregnant women
Pfizer swings to small profit as vaccines begin to roll out
Pfizer reassures Europe over coronavirus vaccines as pandemic surges
US experts debate Pfizer COVID-19 vaccine in live event
BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, an oral JAK3 Inhibitor, for the Treatment of Patients with Alopecia Areata
Pfizer Initiates Pivotal Phase 3 Program for Investigational Hemophilia B Gene Therapy Fidanacogene Elaparvovec
Copyright © 2024